Price Alert

CVRx Inc. (CVRX)

NASDAQ: CVRX · Real-Time Price · USD

7.24

-0.48 (-6.22%)

At close: Aug 14, 2025, 3:59 PM

7.24

0.07%

After-hours: Aug 14, 2025, 04:20 PM EDT

-6.22% (1D)

Bid	7
Market Cap	189.21M
Revenue (ttm)	54.65M
Net Income (ttm)	-52.25M
EPS (ttm)	-2.06
PE Ratio (ttm)	-3.51
Forward PE	-3.8
Analyst	Buy

Ask	7.6
Volume	337,247
Avg. Volume (20D)	300,815.7
Open	7.58
Previous Close	7.72
Day's Range	7.03 - 7.67
52-Week Range	4.30 - 18.55
Beta	1.23

About CVRX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CVRX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CVRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

CVRx Inc. is scheduled to release its earnings on Oct 28, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-9.8%

CVRx shares are trading lower after the company re... Unlock content with Pro Subscription

1 month ago

+19.01%

CVRx shares are trading higher after the company announced its Barostim implant implant is set for a $45,000 medicare reimbursement for procedures performed in the outpatient setting.

News

1 week ago · fool.com

CVRx (CVRX) Q2 Revenue Jumps 15%

1 week ago · seekingalpha.com

CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript

Call Start: 16:30 January 1, 0000 5:09 PM ET CVRx, Inc. (NASDAQ:CVRX ) Q2 2025 Earnings Conference Call August 04, 2025, 04:30 PM ET Company Participants Jared Oasheim - Chief Financial Officer Kevin ...

1 week ago · zacks.com

CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates

CVRx (CVRX) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to a loss of $0.65 per share a year ago.

2 weeks ago · zacks.com

CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

CVRx (CVRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 weeks ago · zacks.com

CVRx (CVRX) Surges 19.0%: Is This an Indication of Further Gains?

CVRx (CVRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

1 month ago · seekingalpha.com

CVRx: Sell-Off Ignores Its True Potential

CVRx offers a unique, FDA-approved heart failure therapy with Medicare reimbursement, positioning it for significant market adoption and growth. The recent share price drop is an overreaction to sales...